Table 2 in Assessment of FDA-approved drugs against StrongyloideS rAtti in vitro and in vivo to identify potentially active drugs against strongyloidiasis

Table 2 IC 50 values of levamisole against larval and adult S. ratti at 24, 48, and 72 h Developmental stageEvaluation time point (h)Concentration tested (µM)1001010.1IC50 valueL32479.5 (8.4)73.3 (4.5)55.2 (25.2)14.2 (1)2.054894 8 (2.5)92.7 (2.9)90.3 (3.0)16.8 (0.7)0.257298.4 (2.8)97.1 (2.6)91.7 (4.4)28.45 (2.8)0.12Adult2439.1 (2.3)33.1 (2.1)30.8 (1.9)20.4 (5.6)>1004887.5 (4.5)84.6 (2.3)75.0 (3.1)25.5 (0)0.357292.7 (2.2)82.8 (1.4)76.8 (2.3)43.9 (3.5)0.11